These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 2946402

  • 1. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL, Fischer PH.
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [Abstract] [Full Text] [Related]

  • 2. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL, Mulcahy RT, Miller EM, Allegra CJ, Fischer PH.
    Biochem Pharmacol; 1989 Jan 01; 38(1):51-9. PubMed ID: 2462882
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL, Fischer PH.
    Cancer Res; 1985 Jul 01; 45(7):2967-72. PubMed ID: 4005834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.
    Carli D, Honorat M, Cohen S, Megherbi M, Vignal B, Dumontet C, Payen L, Guitton J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct 01; 877(27):2937-44. PubMed ID: 19620028
    [Abstract] [Full Text] [Related]

  • 7. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA, Tseng BY, Goulian M.
    Mol Pharmacol; 1982 Jan 01; 21(1):211-6. PubMed ID: 6215571
    [Abstract] [Full Text] [Related]

  • 8. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.
    Sato S, Kohno K, Hidaka K, Hisatsugu T, Kuwano M, Komiyama S.
    Anticancer Drug Des; 1993 Aug 01; 8(4):289-97. PubMed ID: 8240657
    [Abstract] [Full Text] [Related]

  • 9. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA, Briggle TV, Greer S.
    Cancer Res; 1987 May 01; 47(9):2354-62. PubMed ID: 2952263
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB, Klubes P.
    Cancer Res; 1985 Sep 01; 45(9):4249-56. PubMed ID: 2411399
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL, Rustum YM, Ledesma EJ, Mittelman A, Creaven PJ.
    Cancer Res; 1982 Jul 01; 42(7):2930-7. PubMed ID: 6211226
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
    Tanaka M, Kimura K, Yoshida S.
    Cancer Res; 1983 Nov 01; 43(11):5145-50. PubMed ID: 6225512
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
    Curtin NJ, Harris AL, Aherne GW.
    Cancer Res; 1991 May 01; 51(9):2346-52. PubMed ID: 2015598
    [Abstract] [Full Text] [Related]

  • 14. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
    Grem JL.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 3):56-65. PubMed ID: 1557658
    [Abstract] [Full Text] [Related]

  • 15. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ, Allegra CJ, Sinha B, Grem JL.
    Oncol Res; 1994 Apr 01; 6(12):581-91. PubMed ID: 7787251
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the activation of fluorodeoxyuridine by substrate competition and feedback inhibition in 647V cells.
    Vazquez-Padua MA, Risueno C, Fischer PH.
    Cancer Res; 1989 Feb 01; 49(3):618-24. PubMed ID: 2521299
    [Abstract] [Full Text] [Related]

  • 17. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
    Fernandes DJ, Cranford SK.
    Biochem Pharmacol; 1985 Jan 01; 34(1):125-32. PubMed ID: 3155614
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
    Chu E, Chu MY, Darnowski JW, Chen ZH, Pan BC, Chu SH.
    Cancer Res; 1992 Apr 01; 52(7):1729-36. PubMed ID: 1532344
    [Abstract] [Full Text] [Related]

  • 19. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U, Lönn S, Nylen U, Winblad G.
    Cancer Res; 1989 Mar 01; 49(5):1085-9. PubMed ID: 2521812
    [Abstract] [Full Text] [Related]

  • 20. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF, Moir RD, Bertino JR, Handschumacher RE.
    Cancer Res; 1985 Jul 01; 45(7):3155-60. PubMed ID: 3159474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.